Krystal Biotech Cash from Financing (TTM) Analysis

Krystal Biotech Inc (KRYS)

159.05 -2.99 (-1.85%) USD | NASDAQ | Apr 24, 16:00

158.98 -0.06 (-0.04%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	202.75M
September 30, 2023	203.20M
June 30, 2023	191.93M
March 31, 2023	37.36M
December 31, 2022	35.35M
September 30, 2022	234.35M
June 30, 2022	233.74M
March 31, 2022	202.84M
December 31, 2021	347.68M
September 30, 2021	145.75M
June 30, 2021	144.41M
March 31, 2021	262.08M
December 31, 2020	118.02M

Date	Value
September 30, 2020	118.18M
June 30, 2020	131.18M
March 31, 2020	107.73M
December 31, 2019	107.52M
September 30, 2019	171.51M
June 30, 2019	167.90M
March 31, 2019	73.88M
December 31, 2018	73.85M
September 30, 2018	8.866M
June 30, 2018	49.48M
March 31, 2018	51.47M
December 31, 2017	51.77M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

35.35M

Minimum

Dec 2022

347.68M

Maximum

Dec 2021

166.50M

Average

167.90M

Median

Jun 2019

Cash from Financing (TTM) Benchmarks